Publication

Safety and pharmacokinetic comparison between fenofibric acid 135 mg capsule and 110 mg enteric-coated tablet in healthy volunteers

See how enteric‑coated tablet shows higher bioavailability and delayed peak vs capsule, analysed using Phoenix…

Certara2023 年 6 月 16 日

Publication

Liquid Chromatography-Tandem Mass Spectrometry Method for Detection and Quantification of Meloxicam and 5′-Carboxymeloxicam in Oral Fluid Samples

Learn how oral‑fluid LC‑MS/MS enables minimally invasive meloxicam PK/PD assessment, analysed using Phoenix WinNonlin.

Certara2023 年 6 月 15 日

Case Study

利用药代动力学建模和科学传播专长推进肉样瘤病药物项目

Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…

Certara2023 年 6 月 1 日

Publication

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis

Find out how sex affects ivermectin peripheral distribution; infection status does not, modelled using Phoenix…

Certara2023 年 6 月 1 日

Conference

American College of Toxicology 2026 Annual Meeting

– – Booth

Kevin Snyder, PhD2023 年 5 月 24 日

Conference

ACoP 2026

Certara2023 年 5 月 24 日

Publication

Effects of plateau hypoxia on population pharmacokinetics and pharmacodynamics of metformin in patients with Type 2 diabetes

Explore how high‑altitude hypoxia increases metformin AUC and half‑life; PK‑PD modelling supports extended dosing intervals.

Certara2023 年 4 月 28 日

Publication

Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study

Discover how AUC/MIC ≥ 66.9 predicts efficacy; modelling supports 75–100 mg q12h dosing for CRO…

Certara2023 年 4 月 28 日

Publication

Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Explore how tumor growth inhibition modeling can support go/no-go decisions in early Phase Ib/II oncology…

Certara2023 年 3 月 24 日

Publication

Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans

See how tablet and capsule are bioequivalent; food delays Tmax without affecting exposure, analysed using…

Certara2023 年 3 月 17 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

建模与模拟

Safety and pharmacokinetic comparison between fenofibric acid 135 mg capsule and 110 mg enteric-coated tablet in healthy volunteers

Liquid Chromatography-Tandem Mass Spectrometry Method for Detection and Quantification of Meloxicam and 5′-Carboxymeloxicam in Oral Fluid Samples

利用药代动力学建模和科学传播专长推进肉样瘤病药物项目

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis

American College of Toxicology 2026 Annual Meeting

ACoP 2026

Effects of plateau hypoxia on population pharmacokinetics and pharmacodynamics of metformin in patients with Type 2 diabetes

Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study

Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans

订阅时事通讯

快捷链接

解决方案

联系我们